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Infectious agents have been increasingly recognized as bona fide etiologic factors of human 
malignancies, particularly gastrointestinal cancers. The estimated total of infection-
attributed malignancies per year is 1.9 million cases, accounting for 17.8% of the global 
cancer burden (Parkin, 2006). Given that colorectal cancer (CRC) is the third most common 
incident cancer worldwide (World health organization, 2003), it seems prudent to explore 
the role of microbial pathogens in colorectal carcinogenesis. By elucidating the probable 
mechanisms by which infectious agents contribute to colorectal oncogenesis, the 
management of CRC may one day parallel what is already in place for cancers such as 
gastric lymphoma and cervical cancer. Antimicrobial therapy and vaccination against some 
of these infections may herald a future with a curtailed role for traditional therapies of 
surgery and chemo-radiotherapy. 
Unlike gastric cancer, which is chiefly linked to a single infectious agent, multiple organisms 
may contribute to the genesis of CRC. Epidemiological and experimental evidence strongly 
implicate several bacterial and parasitic agents in promotion of colorectal carcinogenesis. 
Most of these agents incite continual inflammation, which generates a procarcinogenic 
microenvironment (Parsonnet, 1995; Vennervald & Polman, 2009). Viruses have not attained 
the same status as other microorganisms as probable causative agents, though merit 
attention because of their inherent oncogenic properties and the increasing strength of their 
association with other malignancies (McLaughlin-Drubin & Munger, 2008). Yet, putative 
viral agents seemingly display an immense geographic variation that has led to much 
debate regarding the relative importance of one organism versus another. The present 
review summarizes the data available on the possible relationship of certain micro-
organisms and CRC. These include but not limited to Helicobacter pylori, Streptococcus bovis, 
Bacteroides fragilis, JC virus (JCV), and human papillomavirus (HPV), and intestinal 
schistosomes. The consistency and nature of these associations are discussed, as are the 
mechanisms whereby each pathogen participates in the malignant transformation of the 
colonic mucosa.  
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2. Bacteria  
2.1 Helicobacter pylori 
H. pylori is a gastric microbiome that colonizes approximately 50% of the population 
worldwide (EUROGAST study group, 1993). Gastric infection with H. pylori fosters chronic 
inflammation and significantly increases the risk of developing peptic ulcer disease and 
gastric cancer. Indeed, the bacterium has been designated by the International Agency for 
Research in Cancer (IARC, 1994), as a class I carcinogen in human causing gastric cancer. 
Recently, promotion of tumour development by H. pylori infection in extragastric target 
organs, such as the colorectum, has been reported, though causal relationship is presently 
controversial.  
Cancer in human 
Numerous comparative and case-control studies have examined the relationship between H. 
pylori IgG seropositivity and colorectal neoplasia risk, but the results have been inconsistent. 
While some studies demonstrated positive correlations between colorectal neoplastic 
lesions, especially adenomas, and H. pylori seroprevalence (Aydin et al., 1999; Hartwich et 
al., 2001b; Meucci et al., 1997; Mizuno et al., 2005; Zumkeller et al., 2007), others showed null 
or inverse associations (Moss et al., 1995; Penman et al., 1994; Fireman et al., 2000; Shmuely 
et al., 2001; Siddheshwar et al., 2001; Machida-Montani et al., 2007; D’Onghia et al., 2007). 
Most of these studies were, however, confounded by uncontrolled extraneous variables. 
Breuer-Katschinski et al. (1999) compared H. pylori serostatus between 98 colorectal 
adenoma patients and age/sex-matched hospitalized and populations-based control groups. 
The results clearly demonstrated an increase in the risk of colorectal adenoma in association 
with H. pylori infection following adjustment for dietary and lifestyle factors. Importantly, 
two case-control studies nested in large population-based cohorts failed to establish any 
association between H. pylori seroprevalence and incident CRC, irrespective of adjustment 
for potential confounders (Thorburn et al., 1998; Limburg et al., 2002). In each study, the 
presence of H. pylori was determined in subjects who developed CRC years after serum 
donation. The inconclusive findings in these studies have been partially attributed to small 
sample size, lack of control heterogeneity, and incomplete colonoscopic evaluation (Takeda 
& Asaka, 2005). Besides, serologic methods may not always reflect real-time H. pylori 
infection and likely yield positive results for infections caused by Helicobacter species other 
than H. pylori, which commonly colonize the human colonic mucosa (Keenan et al., 2010). 
Other studies have utilized more reliable diagnostic tools for detection of H. pylori infection. 
Lin et al. (2010) conducted a cross-sectional study using biopsy urease test, and 
demonstrated a significantly increased risk of colorectal adenoma among H. pylori infected-
patients, particularly those with concomitant metabolic syndrome. Conversely, two case 
control studies, using 13C-Urea breath test (UBT), did not substantiate any significant 
associations of H. pylori infection with colorectal tumours (Penman et al., 1994; Liou et al., 
2006). Fujimori et al. (2005) evaluated 699 patients for H. pylori infection using combination 
of three tests; UBT, rapid urease test, and gastric biopsy histology. Their analysis revealed a 
significantly higher prevalence of colorectal adenoma and adenocarcinoma among H. pylori-
positive female patients compared to their H. pylori-free counterparts.  
Of note, in a metanalysis of 11 case-control studies, the summary odd ratio for the 
association of H. pylori infection with the risk for colorectal carcinoma or adenoma was 
found to be 1.4 (95% CI, 1.1–1.8). Different testing methods were, nevertheless, combined to 
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assess the H. pylori infection status in these studies (Zumkeller et al., 2006). More recently, a 
meta-analysis comprising 13 studies and 1709 patients with colorectal neoplasms, arrived at 
summary odd ration of 1.49 (95% CI 1.17–1.91). Further analysis of studies using serologic 
response as the sole indicator of infection revealed a higher summary odd ratio of 1.56 (95% 
CI, 1.14–2.14) (Y. S. Zhao et al., 2008).  
Recently, Soylu et al. (2008) have investigated the presence of H. pylori in colorectal 
neoplasms using immunohistochemical methods, which allowed more accurate detection of 
the non-spiral forms of the bacterium. The prevalence of H. pylori was higher in villous type 
polyps than in tubular type polyps and adenocarcinomas. Contrary to this finding, Jones et 
al. (2007) demonstrated that villous adenoma had the lowest rate of H. pylori positivity 
compared to other premalignant and malignant colonic lesions. Their results also showed 
significant associations of H. pylori positivity with tubular and tubulovillous adenomas, and 
adenocarcinomas, but not with villous adenomas.  
Likewise, studies employing PCR analysis for detection of H. pylori genomic material in the 
cancerous tissue have yielded conflicting results. A Swedish group detected H. pylori DNA 
in 27% of CRC specimens (Bulajic et al., 2007). In contrast, Grahn et al. (2005) identified H. 
pylori DNA in 1.2% of the malignant tissues and, unexpectedly, in 6% of normal mucosal 
samples among patients with CRC. Additionally, there was no statistical correlation 
between H. pylori PCR positivity and CRC. This finding was further confirmed in a later 
study on a separate population (Keenan et al., 2010). 
Cancer in experimental animals 
Studies have shown that amidated gastrins have no stimulatory effect on colon mucosal 
growth or progression of colon cancer in different experimental models (Hakanson et al., 
1986, 1988). Others demonstrated that non-amidated gastrins, including progastrin and Gly-
gastrin, have a mitogenic effect on the colonic mucosa in transgenic mice (T.C. Wang., 1996; 
Koh et al., 1999). Singh et al. (2000a, 2000b) reported that transgenic mice with elevated 
plasma progastrin, but not amidated gastrins, exhibit increased aberrant crypt foci, 
adenomas, and adenocarcinomas after treatment with azoxymethane, whilst no tumours 
developed in mice exposed to either progastrin or azoxymethane only. These results suggest 
that non-amidated gastrin is not a carcinogen on its own, but rather promotes oncogenic 
progression. 
Mechanisms/Mechanistic studies 
Various pathogenetic mechanisms have been suggested by which H. pylori exerts its 
oncogenic potential. First, persistent H. pylori exposure induces hypergastrinemia, which is a 
putative trophic factor for the human colorectal mucosa, thereby increasing the mutation 
susceptibility (Renga et al., 1997). Moreover, studies showed that most human colon cancers 
secrete gastrin, primarily non-amidated gastrins, which likely function in autocrine fashion 
(Baldwin et al., 1998). Non-amidated gastrin induces proliferation and invasiveness of 
human tumour cells in vitro (Kermorgant & Lehy, 2001). In conjunction with these findings, 
the overexpression of cyclooxygenase-2 (COX-2) was shown to stimulate the cancer cells to 
release excessive amount of prostaglandin E2 (PGE2), leading to further proliferation 
(Hartwich et al., 2001b).  
Although some reports, including a well-controlled prospective study, provided statistical 
evidence that high fasting plasma gastrin level is associated with increased risk of colorectal 
adenoma and carcinoma (Hartwich et al., 2001b; Thorburn et al., 1998; Georgopoulos et al., 
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2006), others showed no associations (Penman et al., 1994; Fireman et al., 2000; Machida-
Montani et al., 2007; Robertson et al., 2009). In a majority of these studies only amidated 
gastrin was measured, which may have contributed to the discrepancy in results (Dickinson, 
1995). In a recent study, circulating forms of both amidated and non-amidated gastrins were 
measured. Non-amidated gastrins were significantly higher in patients with colorectal 
carcinomas, compared with levels in control patients (Ciccotosto et al., 1995). 
Second, H. pylori-related chronic gastritis might contribute to colorectal carcinogenesis by 
reducing gastric acid secretion with consequent alteration in the normal gastrointestinal 
flora (Kanno et al., 2009). Another possibility is that CagA protein (Fig 1.), which is 
produced by virulent strain of H. pylori, may contribute to colorectal carcinogenesis by 
inducing an enhanced inflammatory response and potentiating gastrin secretion (Peek et al., 
1995; J.H. Kim et al., 1999). As for the correlation between colorectal neoplasia and CagA+ H. 
pylori serostatus, three studies indicated positive correlations between CagA+ H. pylori 
seropositivity and colorectal tumours (Hartwich et al., 2001b; Shmuely et al., 2001; 
Georgopoulos et al., 2006), while two other studies found no such correlation (Zumkeller et 
al., 2007; Limburg et al., 2002).  
 
Fig. 1. Illustration of the possible mechanisms of bacterial-toxin-induced carcinogenesis. 
2.2 Streptococcus bovis  
S. bovis, a nonenterococcal lancefield group D streptococcus, is a transient colonic commensal 
with fecal carriage rate of 5 - 13 % in healthy adults (Potter et al., 1998; Dubrow et al., 1991), 
and accounts for 11-12% of infective endocarditis (Ballet et al., 1995; Kupferwasser et al., 
1998). Traditionally, S. bovis has been classified into three distinct biotypes; I, II/1, and II/2, 
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based on phenotypical and genetic characteristics (Coykendall & Gustafson, 1985). Further 
studies using phylogenetic analysis allowed clear and unambiguous differentiation of 
human clinical isolates and indicated that all strains of S. bovis I and II/2 be identified as S. 
gallolyticus (Schlegel et al., 2003). The latter accounts for most of the human strains isolated 
from blood or faeces, and is often responsible for endocarditis cases associated with colonic 
cancer (Schlegel et al., 2003).  
Cancer in humans 
The association between S. bovis endocarditis and colorectal carcinoma was first brought to 
light by Keusck (1974). Subsequent case studies showed a wide range of prevalence of 
colorectal neoplasms in patients with S. bovis bacteraemia (6 - 67%), depending on the 
diligence with which the diagnosis was sought (Pigrau et al., 1988; Klein et al, 1979; H.W. 
Murray & Roberts, 1978; Friedrich et al., 1982a; Reynolds et al., 1983; Zarkin et al., 1990; 
Gold et al, 2004; Alazmi et al, 2006; Beeching et al., 1985). Additionally, some patients 
developed new colonic tumours 2 to 4 years following the incidence of S. bovis endocarditis, 
pointing to a possible temporal relationship between the two events (Zarkin et al., 1990; 
Robbins & Klein, 1983; Muhlemann et al., 1999; Friedrich et al., 1982b). Other studies 
reported that patients with S. bovis endocarditis had significantly higher rates of colorectal 
neoplasms than those with endocarditis due to other pathogens or non-endocarditis patients 
(Pergola et al., 2001; Hoen et al., 1994). More particularly, Ruoff et al. (1989) showed that S. 
bovis I bacteraemia was highly correlated with malignant and premalignant colonic lesions, 
compared to bacteraemia due to other S. bovis biotypes. This conclusion was affirmed by 
several recent analyses, in which the incidence of colonic tumours in patients with S. bovis I 
infection ranged between 27 - 94% (Herrero et al., 2002; Tripodi et al., 2004; Corredoira et al., 
2008; Vaska & Faoagali, 2009; Ruoff et al, 1999). 
Several investigators have studied the association between the fecal carriage rate of S. bovis 
and both malignant and premalignant colorectal lesions, with the results being 
contradictory (Klein et al., 1977; Potter et al., 1998; Norfleet & Mitchell, 1993; Burns et al., 
1985). Comparing the growth of S. bovis from tissue biopsy of adenomas or carcinomas did 
not show increased frequency compared to normal mucosa from the same patients or non-
cancer-patients group (Potter et al., 1998; Norfleet & Mitchell, 1993). In contrast, Abdulamir 
et al. (2010), using bacteriological studies and molecular techniques to detect S. gallolyticus in 
tissue or faeces, revealed a significantly higher frequency of S. gallolyticus isolation from 
tumorous and non-tumorous tissue in CRC patients than from normal mucosa in control 
subjects. In parallel, the faecal carriage rate of S. gallolyticus was similar in cancer and control 
groups.  
In another aspect, Darjee and Gibb (1993) used immunoblotting and enzyme-linked 
immunosorbent assay (ELISA) to compare anti-S. bovis IgG levels in sera of 16 colonic cancer 
patients and 16 age-matched controls. Immunoblot assay showed no significant difference in 
the serologic parameters between patients and controls, whilst ELISA demonstrated higher 
median S. bovis IgG antibody titres in patients with colonic cancer, compared to controls. 
Using immunocapture mass spectrometry, Tjalsma et al. (2006) showed a higher frequency 
of anti-S. bovis seropositivity in patients with colonic polyps and cancer than age-matched 
controls. Importantly, recent studies reported that CRC and adenoma were associated with 
higher levels of serum anti-S. gallolyticus IgG antibody in comparison with healthy and 
tumour-free control subjects (Abdulamir et al., 2009).  
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It is clear that a strong association does exist between symptomatic S. bovis infection and 
colorectal neoplasia, which has important clinical implications. Patients who have S. bovis 
bacteraemia, with or without endocarditis, require extensive endoscopic evaluation for 
occult premalignant and malignant colonic cancer (Konda & Duffy, 2008). Further, recent 
evidence indicates that serum antibodies to S. bovis represent a promising potential for early 
diagnosis and prevention of CRC (Tjalsma et al., 2006). 
Cancer in experimental animals 
Studies have shown that administration of S. bovis or S. bovis wall extracted antigens (WEA) 
to azoxymethane- treated rats resulted in almost two-fold increase in the number of aberrant 
colonic crypts, compared to azoxymethane-only treated control rats. Fifty percent of the rats 
receiving WEA developed colonic adenomas, whereas no tumour was detected in the other 
groups. It is noteworthy to mention that normal rats did not develop hyperplastic colonic 
crypts upon treatment with S. bovis suspension, implying that S. bovis proteins are involved 
in promoting rather than initiating oncogenesis (Ellmerich et al., 2000b). Similar results were 
obtained by Biarc et al., (2004) who also reported that a purified form of S. bovis WEA (S300 
fraction) is even more potent inducer of neoplastic progression than WEA or the intact 
bacteria.  
Mechanisms/Mechanistic studies 
Although Klein et al. (1977) originally theorized that S. bovis may play a role in producing 
carcinogens in the large bowel, recent data showed that S. bovis wall proteins (Fig. 1.) have 
proinflammatory potential and procarcinogenic properties (Nguyen et al., 2006). In vitro 
studies indicated that activation of human colonic epithelial cell line Caco-2 by S. bovis cell 
wall proteins, especially S300 fraction, resulted in significant increase in IL-8 production, 
COX-2 expression, and PGE2 release (Biarc et al., 2004), whereas binding of S. bovis activated 
human leucocytes cell line to release TNF-ǂ (Ellmerich et al., 2000a). These results are in 
agreement with those obtained in in vivo experiments showing that S. bovis as well as cell 
wall antigens from this bacterium are able to increase the production of IL-8 and PGE2 in the 
colonic mucosa of rats (Ellmerich et al., 2000b; Biarc et al., 2004). More recently, human 
studies have provided evidence for a strong association between S. gallolyticus IgG 
seropositivity and nuclear factor kappa B (NF-κB) and IL-8 expression in tumorous sections 
of both colorectal adenomas and carcinomas (Abdulamir et al., 2009). Using quantitative 
PCR analysis to measure bacterial count in cancerous tissue, the same group observed a 
positive correlation between the levels of expression of IL-1, COX-2, and IL-8 and the S. 
gallolyticus load in tumorous colorectal tissue (Abdulamir et al., 2010). Apart from its 
inflammatory potential, S. bovis cell wall proteins may activate mitogen-activated protein 
kinases (MAPKs), stimulating a proliferative response in the host cells and increasing the 
likelihood of cell transformation (Biarc et al., 2004). 
Notably, the chemokine 1L-8 is potent angiogenic factor and neutrophil chemoattractant (Li 
et al., 2001), which as well as other cytokine such as TNF-ǂ, IL-1ǃ, and IL-6, trigger a chronic 
inflammation with resultant production of highly mutagenic reactive oxygen and nitrogen 
species (Ohshima & Bartsch., 1994). COX-2, through production of excessive amounts of 
prostaglandins, inhibits apoptosis, and promotes tumour cell proliferation, angiogenesis, 
and tumour invasiveness (Hartwich et al., 2001a). In addition, activation of NF-κB pathway 
induces the expression of downstream mediators such as COX-2, TNF-ǂ, and IL-6, all 
contributing to inflammation-related tumorigenesis (S. Wang et al., 2009).  
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2.3 Bacteroides fragilis 
B. fragilis is a gram-positive, anaerobic colonic microflora in most mammals, and is the 
leading cause of anaerobic bacteraemia and intraabdominal suppurative infection in human 
adults (Wexler et al., 2007). The pathogenicity of this bacterium is attributed to several 
virulence determinants, including a recently identified metalloprotease toxin, called 
fragilysin. Fragilysin-producing B. fragilis, termed enterotoxigenic B. fragilis (ETBF), causes 
acute inflammatory diarrheal disease and asymptomatically colonizes up to 20 -35 % of 
adults (Sears et al., 2008). As well, it has been recently linked to flare-ups of inflammatory 
bowel disease (Basset et al., 2004; Prindiville et al., 2000).  
Cancer in human 
The epidemiological evidence on the association B. fragilis infection and colorectal neoplasia 
is limited. Early studies by Legakis et al. (1981) indicated that the incidence of fecal B. fragilis 
in CRC patients was significantly higher than in healthy subjects, suggesting a possible role 
for B. fragilis in colon carcinogenesis. Moore et al. (1995), however, did not find any 
significant difference in the frequency of fecal carriage of B. fragilis between colorectal 
adenoma patients and low-risk healthy controls. Similarly, a seroepidemiological study 
showed lack of associations between B. fragilis IgG serostatus and colorectal adenoma and 
carcinoma (Abdulamir et al., 2009). Using PCR methods, Toprak et al. (2006) recently 
compared the prevalence of ETBF in stool specimens from 73 patients with CRC with 59 
age-matched controls. The frequency of isolation of the organism was significantly higher in 
the CRC patients (38%) than in the control group (12%). These findings, however, have not 
been replicated in another population. 
Cancer in experimental animals 
Studies of murine models have demonstrated that ETBF induced persistent subclinical 
colonic inflammation and hyperplasia in specific pathogen-free C57BL/6 mice (Rhee et al., 
2009). The same group used the adenomatous polyposis coli multiple intestinal neoplasia 
(ApcMin/+) mice to model human CRC. ETBF-colonized ApcMin/+ mice developed 
inflammatory colitis and unusually early onset microadenomas. In addition, de novo colon 
tumours appeared as early as 4 weeks and distributed predominantly in the distal colon, 
similar to those found in humans (Wu et al., 2009).  
Mechanisms/Mechanistic studies 
The current experimental evidence suggests a potential role of fragilysin in the oncogenic 
transformation of the colonic mucosa (Fig. 1.). In vitro studies have shown that fragilysin 
induces IL-8 expression and NF-κB activation in human colonic epithelial cell lines HT29 
and Caco-2 (Sanfiloppo et al., 2000; J.M. Kim et al., 2001). IL-8 is a potent neutrophil 
chemokine, whereas NF-κB is an essential transcription factor that regulates neutrophils 
migration and the host epithelial cell chemokine response (J.M. Kim et al., 2002). 
Additionally, it was demonstrated that fragilysin binds to human colonic epithelial cell line 
HT29/C1 and stimulates cleavage of the tumour suppressor protein, E-cadherin. The 
resultant nuclear translocation of the adhesion molecule ǃ-catenin causes increased 
expression of T-cell factor-target genes, including c-myc, with consequent persistent cellular 
proliferation (Wu et al., 1998, 2003).  
Recent showed that all ETBF-induced tumours in ApcMin/+ mice exhibited intense Stat3 
protein activation, which in turn induces dominant colonic IL-17-producing CD4+ T-cells 
infiltrate. Tumour formation was significantly inhibited by administration of blocking 
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antibodies to IL-17 (Wu et al., 2009). The latter is known to promote tumour growth in vitro 
and in vivo through induction of IL-6 synthesis (L. Wang et al., 2009). These results 
emphasized the contribution of endogenous T cell immune response in ETBF infection- 
derived colorectal carcinogenesis.  
In addition, B. fragilis may indirectly promote colon carcinogenesis through production of 
cytotoxic metabolites such as deoxycholic acid and fecapentaenes. Studies have shown that 
deoxycholic acid induce proliferation of colonic cells in vitro and promote colonic tumour 
progression in experimental animals (Peiffer et al., 1997; T. Hori et al., 1998). Several 
epidemiological studies found a positive association between high faecal deoxycholic acid 
concentration and colorectal adenoma and carcinoma risk (Little et al., 2002; Reddy & 
Wynder, 1977), including a prospective study assessing faecal deoxycholic acid levels before 
the diagnosis of colorectal tumours (Kawano et al., 2010). Fecapentaenes are other fecal 
mutagens synthesized by Bacteroides species, which were shown to be highly genotoxic in 
both mammalian and bacterial in vitro assays (Plummer et al., 1986; Curren et al., 1987). 
Clinical studies, however, indicated that fecal fecapentaenes levels are not associated with 
colorectal adenomas and inversely associated with carcinomas (de Kok et al., 1993; 
Schiffman et al., 1989). It was concluded that if fecapentaenes form a relevant factor in 
colorectal carcinogenesis, their role is more likely to be related to the transformation of late 
adenomas into malignant tumors. 
2.4 Other bacterial species 
There are very few reports on the role of enteric bacterial flora other than B. fragilis in 
colorectal tumorigenesis. Severe distal colitis, rectal dysplasia, and adenocarcinoma were 
observed in IL-10 knockout mice colonized with Enterococcus faecalis (Balish & Warner, 2002; 
S.C. Kim et al., 2005). E. faecalis has been shown to produce reactive oxygen species and 
induce DNA damage, aneuploidy and tetraploidy in colonic epithelial cells both in vivo and 
in vitro (Huycke et al., 2002; X. Wang et al., 2008). Furthermore, it was demonstrated that E. 
faecalis promotes chromosomal instability in mammalian cells, possibly through COX-2 
dependent mechanism (X. Wang & Huycke, 2007). Epidemiological studies, however, could 
not establish any association between colonic colonization of E. faecalis and development of 
CRC (Winters et al., 1998). 
Studies showed that mucosa-associated and intramucosal Escherichia coli were significantly 
associated with Crohn’s disease, and colorectal adenomas and carcinomas (Swidsinski et al., 
1998; Martin et al., 2004). E. coli stimulates IL-8 release from the I407 and HT29 cell lines 
(Martin, 2004), and acts synergistically with E. faecalis to induce aggressive pancolitis with 
reactive atypia in IL-10 deficient mice (S.C. Kim et al., 2007). Recently, Maddocks et al. 
(2009) reported that enteropathogenic E. coli downregulates DNA mismatch repair proteins 
which increases the susceptibility of colonic epithelial cells to mutations and therefore 
promotes colonic tumorigenesis.  
3. Viruses 
3.1 Human papilloma virus 
Human papilloma virus is a double stranded DNA virus that is transmitted through direct 
contact with infected skin or mucous membrane, and causes the most common sexually 
transmitted disease among sexually active individuals (Koutsky, 1997). While it is well 
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established that HPV is a necessary cause of cervical cancer, studies suggest HPV may be 
involved in the malignant transformation of the oropharynx and the anogenital tract 
(D’Souza et al., 2007;  Steenbergen et al.,  2005). There are more than 100 subtypes of HPV; 
some of these subtypes, particularly HPV-16 and HPV-18, are referred to as high risk 
oncogenic infections (Wiley & Masongsong, 2006; Munoz et al., 2003).  
Cancer in human 
Early case studies have failed to show any association between HPV infection and colorectal 
carcinoma in relatively small samples of colorectal carcinoma tissue (Boguszakova et al., 
1988; Koulos et al., 1991; Shah et al., 1992; Shroyer et al., 1992). Subsequent studies have 
employed more stringent methods for HPV detection, including PCR and 
immunohistochemistry. Despite the variation in the control specimen, all studies confirmed 
an association between HPV detection rates, specifically subtypes 16 and 18, and CRC with 
odd ratio ranging between 2.7 (95% CI, 1.1–6.2) and 9.1 (95% CI, 3.7–22.3). (Cheng et al., 
1995; Kirgan et al., 1990). Moreover, the strength of association was related to the degree of 
tumour dysplasia. On the contrary, two of three large prospective cohort studies, with 
sample sizes ranging between 21,222 and 104,760 cases of cervical cancer, reported no 
increased risk of subsequent CRC in patients with cervical cancer (Weinberg et al., 1999; 
Rex, 2000). The other study has shown increased risk of anorectal cancer among patients 
with cervical cancer, though with lack of clarity over whether it was due to HPV infection or 
radiation (Chaturvedi et al., 2007).  
Mechanism/ mechanistic studies 
The oncogenic property of the virus is related to early genes which encode the regulatory 
proteins E6 an E7. It was hypothesized that these proteins interact and inactivate suppressor 
genes p53 and pRb, and thus inhibiting apoptosis (Steenbergen et al., 2005). Although about 
50% of all colorectal cancer has mutated p53 (Slattery et al., 2002), Buyru et al. (2003) 
reported that only 3.6% of HPV-positive colorectal cancers contained mutations in p53, 
suggesting that HPV may have direct oncogenic effects independent of any p53 mutations.  
3.2 John Cunningham virus 
JC virus is a widespread neurotropic polyoma virus, with seroprevalence rates of 39-90% 
among healthy adult population (Kean et al., 2009; Shah, 1996). Primary JCV infection 
typically occurs during early childhood, probably via fecal-oral route, followed by latency of 
the virus in the kidney and gastrointestinal tract (Khalili et al., 2003, Ricciardiello et al., 
2000). The virus may be reactivated in the presence of severe immunosuppression, and 
replicates in the central nervous system causing a fatal demyelinating disease, progressive 
multifocal leukoencephalopathy. Furthermore, there is mounting evidence suggesting that 
JCV infection may be associated with several human malignancies including brain tumours 
and upper gastrointestinal cancers (Caldarelli-Stefano et al., 2000; Del Valle et al., 2001, 2005; 
Shin et al., 2006). 
Cancer in human 
The potential association between JCV infection and colorectal neoplasia has been examined 
using nested PCR, Southern blotting and in situ hybridization techniques. Ten studies, with 
sample sizes ranging from 18 to 186, detected JCV genomic sequences in 9-89% of colorectal 
carcinomas and 5-82% of adenomatous tissue (Laghi et al., 1999; Theodoropoulos et al., 2005; 
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R. Hori et al., 2005; Casini et al., 2005; Enam et al., 2002; Goel et al., 2006; P. Y. Lin et al., 2008, 
Niv et al., 2010a; Karpinski et al., 2011; Jung et al., 2008). Comparing neoplastic tissues with 
normal mucosa, three of these studies showed consistently higher detection rates for JCV in 
colorectal cancerous tissues and adenomas than in normal tissue (Theodoropoulos et al., 
2005; R. Hori et al., 2005; Enam et al., 2002). As well, significantly higher viral copy numbers 
were observed in colorectal carcinomas and adenomas compared to adjacent normal 
mucosa (Laghi et al., 1999; Theodoropoulos et al., 2005). Of note, a sequence of the Mad-1 
variant of JCV, which lacks 98 nucleotides repeats, has been found preferentially in colon 
cancers, raising the possibility that certain strains may be selectively activated in colonic 
epithelial cells (Ricciardello et al., 2001). Other studies have employed real-time PCR, a less 
sensitive molecular technique, to detect JCV genetic material in colorectal carcinomas, 
adenomas, normal mucosa, and urine samples from CRC patients and controls. While JCV 
carrier frequencies in urine were comparable to previously published reports (Agostini et 
al., 1999), none of the neoplastic tissues and less than 1% of the normal tissues tested 
positive for JCV DNA (Newcomb et al., 2004; Campello et al., 2010; Militello et al., 2009). The 
discordant results in previous investigations may be explained by the small sample sizes, 
variable prevalence of viral infection among the studied populations, inherent lack of 
uniformity in the sensitivity of the assay used, and possible laboratory contamination 
particularly in studies where Mad 1 viral sequence was used as a positive template control 
(Newcomb et al., 2004).   
The expression pattern of JCV T-antigen has also been studied in both colorectal neoplastic 
and normal mucosa. About 35%-94% of CRC tissues and 5-50% of colorectal adenomas were 
found to host JCV T-antigen, which is often concentrated in the nucleus (Enam et al., 2002; P. 
Y. Lin et al., 2008; Goel et al., 2006; Link et al., 2009; Nosho et al., 2008, 2009; Ogino et al., 
2009; Selgrad et al., 2008; Jung et al., 2008). The expression of JCV T-antigen was 
significantly higher in colorectal adenomas from liver transplant recipients compared to 
adenomas in normal controls, pointing to a possible etiologic role for immunosuppression 
(Selgrad et al., 2008). Interestingly, viral DNA has always been detected more frequently 
than Tag expression in both colonic adenomas and carcinomas. This suggests that either in 
some samples, the viral copy number is too low to determine expression of the early gene 
or, alternatively, that the growing tumour tends to lose viral sequences (Ricciardello et al., 
2003). In another aspect, two prospective nested case-control investigated the association 
between JC seroprevalence and colorectal neoplasms in large groups of patients from whom 
blood samples were collected months or years before colorectal cancer diagnosis (Rollison et 
al., 2009; Lundstig et al., 2007). Although there was no association between JC seropositivity 
and colorectal cancer, one study showed a significantly increased risk of adenomas among 
seropositive male subjects (Rollison et al., 2009). More recently, Niv et al. (2010b) observed 
positive correlation between the presence of neoplastic colonic lesion and the titre of JCV 
antibody in the serum, pointing to JCV infection as an early event for the formation of 
colorectal adenoma. 
Mechanism/ mechanistic studies 
The JCV T-antigen is a potent oncogenic protein capable of transforming mammalian cells 
and is likely involved the early stages of colorectal carcinogenesis though “hit and run” 
mechanisms. These include disruption of the Wnt signalling pathway and inactivation of 
tumour suppressor genes such as pRb and p53 (Ludlow, 1993). Both in vitro and in vivo 
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studies have shown that coexpression of p53 and JCV T-antigen in CRC cells (Enam et al., 
2002; Nosho et al., 2009; Ricciardello et al., 2003). Similarly, colocalization of T-antigen and 
B-catenin was observed in the nuclei of neoplastic columnar cells (Enam et al., 2002; nosho et 
al., 2009). Cooperativity between B-catenin and JCV T-antigen increased in vitro 
transcription of c-myc, leading to chromosomal instability (Enam et al., 2002). Ricciardiello et 
al. (2003) demonstrated that JCV can induce chromosomal instability in vitro using the 
diploid CRC cell line, which defines loss of heterozygosity (LOH). Subsequent studies 
reported a significant association between JCV T-antigen expression and CRC with LOH 
(Nosho et al., 2009; Goel et al., 2006; Ogino et al., 2009). This deletional event probably 
provides the second hit at the tumour suppressor genes, and eventually leads to clonal 
expansion. The role of DNA hypermethylation has recently been explored in both colorectal 
carcinoma and adenoma, nevertheless the results were contradictory (Nosho et al., 2008, 
2009; Goel et al., 2006). 
3.3 Other viruses 
Epstein-Barr virus (EBV) is a DNA virus with strong association with several 
lymphoreticular malignancies, especially Burkett’s lymphoma, as well as certain epithelial 
tumours such as the nasopharyngeal carcinoma (Parkin, 2006). Additionally, EBV has also 
been reported with gastric cancer (Koriyama et al., 2001; Takada, 2000), breast (Labrecque et 
al., 1995; Bonnet et al., 1999; Fina et al., 2001) and lung cancer (Castro et al., 2001; Han et al., 
2001; M.P. Wong et al., 1995). For colorectal cancer, although early studies have detected 
high rates of EBV infection in colorectal carcinoma tissue, using PCR, 
immunohistochemisrty and fluorescence in situ hybridization (Song et al., 2006; Liu et al., 
2002, 2003), only one study reported significant difference in EBV detection rates between 
colorectal carcinoma tissue and adjacent normal mucosa (Song et al., 2006). Follow-up 
studies failed to show any evidence that EBV was detected at a significantly higher rate in 
colorectal carcinoma (Grinstein et al., 2002; Yuen et al., 1994), even in higher risk 
populations such as patients with ulcerative colitis (N.A. Wong et al., 2003).  
In the case of Cytomegalovirus (CMV), early limited studies have detected CMV genome in 
the colon carcinoma tissue, whereas controls from normal colons and cases of Crohn disease 
were negative (Huang & Roche, 1978; Hashiro et al., 1979).    Further studies then showed 
that CMV was not detected at a significantly higher rate in carcinoma tissue than normal 
tissue by multiple detection methods, such as FISH, immunohistochemistry, or DNA 
hybridization (Hart et al., 1982; Ruger & Fleckenstein, 1985).  It was found that patients with 
colorectal cancer who were treated with chemotherapy had significantly increased CMV IgG 
titre (Avni et al., 1981). However, this finding appeared to be related to CMV infection or 
reactivation secondary to immunosuppression by chemotherapy rather than primary 
infection causing colorectal cancer.  
4. Helminths 
4.1 Schistosoma japonicum 
The epidemiologic parallel between schistosomiasis japonica endemicity and the 
distribution of large bowel cancer has been noted in the eastern provinces of China in the 
1970s (E. S. Zhao, 1981). Subsequently, ecological studies in the same endemic areas showed 
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a strong geographical correlation between the prevalence of schistosomiasis japonica and 
CRC incidence and mortality (Xu & Su, 1984). Likewise, significant association was 
observed between the mortality from CRC and from schistosomiasis japonica in rural China, 
even after adjustment for dietary factors (Chen et al., 1990; Guo et al., 1993). The authors 
attributed the continuing high incidence of colorectal cancer in endemic regions to persistent 
large populations of chronically infected individuals. This conclusion was further bolstered 
by a retrospective cohort study conducted in an endemic area in Japan, where the 
standardized mortality ratio for colonic cancer was significantly high in females who lived 
in the area for 50 years or more (Inaba, 1984). 
More importantly, a case-control study carried out in the endemic area of Jiangsu Province, 
China, showed that the risk of rectal cancer was increased among subjects with a previous 
diagnosis of S. japonicum infection with odds ratios of 4.5 and 8.3 (depending on the type of 
controls used), but the risk of colon cancer was not significantly increased in the same 
patients group (Xu & Su, 1984). A similar investigation in the same endemic area has 
confirmed strong associations between colon cancer and early and late-stage S. japonicum 
infection, regardless of the type of control used for comparison. When the results were 
adjusted to smoking and family history of colon cancer, statistically significant associations 
were still noted. In addition, the estimated relative risk increased with the duration of 
exposure to S. japonicum infection (Mayer & Fried, 2007). Of interest also is a recent matched 
case-control study which reported that patients with chronic schistosomiasis japonica have 
more than three times risk to develop colon cancer than those with no previous exposure to 
schistosomal infection. Moreover, the authors attributed 24% of colon cancer cases to long-
standing schistosomal infestation (Qiu et al., 2005). 
The consensus of available pathological data strongly implicates an association between S. 
japonicum infestation and induction of CRC. In a review of the literature between 1898 and 
1974, 276 cases of schistosomiasis japonica associated with cancer of the large intestine were 
analysed. The results showed significant differences between carcinoma with 
schistosomiasis and ordinary carcinoma in symptoms, age range, sex ratio, and 
histopathologic findings, indicating that schistosomiasis may induce carcinoma (Shindo, 
1976). Ming-Chai et al. (1965) reported similar findings in their study of 90 cases of 
simultaneous CRC and schistosomiasis, and proposed that S. japonicum colitis, in its late 
phases, is a premalignant condition not infrequently leading to cancer. Supporting their 
previous results and giving better insight into the pathogenesis of schistosomal colorectal 
carcinoma, the same group has examined the mucosal changes in the immediate vicinity of 
the tumours of patients with schistosomiasis, and referred to the close similarity between 
certain schistosome-induced lesions and those associated with long-standing ulcerative 
colitis. Pointing to mimicry of cancer evolution in these two clinical entities, they described 
presence of pseudopolyps, multiple ulcers, and hyperplastic ectopic submucosal glands, 
with evidence of oviposition and precancerous and cancerous transformation in these 
lesions (Ming-Chai et al., 1980). It was also demonstrated that the closer to the tumour the 
area is the more ova tend to be detected (Matsuda et al., 1999). In a following study, Ming-
Chai et al. (1981) observed variable degree of colonic epithelial dysplasia in 60% of cases 
with S. japonicum colitis and regarded these changes as the transition on the way towards 
cancer development in schistosomal colonic disease. A similar conclusion was drawn by Yu 
et al. (1991) from their studies on different types of schistosomal egg polyps. 
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Of note, distinct clinico-pathologic characteristics of S. japonicum-related colorectal cancer 
seem emerge from the existing literature. Bearing in mind the early environmental exposure 
to schistosomal infection in childhood, schistosomal colorectal cancer was notably shown to 
occur in younger age group with a maximum age incidence 6 to 16 years earlier than 
ordinary colorectal cancer (Shindo, 1976; Ming-Chai et al., 1965, 1980). Furthermore, the 
gender ratio of male to female in schistosomal colorectal cancer is consistently higher than in 
nonschistosomal cancer (Shindo, 1976; Ming-Chai et al., 1980). This can be attributed to the 
fact that men are more prone to schistosomal infection through contact with cercariae-
infested waters during agricultural activities.  
4.2 Schistosoma mansoni 
The epidemiological evidence associating S. mansoni infection with CRC is lacking, of poor 
quality, or conflicting. Supporting the absence of such a causal association, Parkin et al. 
(1986) pointed out that although there is a great disparity in the geographical distribution of 
S. mansoni, CRC occurs in the African continent with clear uniformity. In a recent hospital-
based study in Uganda and Zimbabwe, Waku et al. (2005) compared 950 cases of infective 
gastrointestinal disease, particularly schistosomiasis and amebiasis, with 249 patient 
controls admitted for various diseases other than GI disease. The cases were thoroughly 
investigated and further stratified into three groups on the basis of the stage of the disease; 
cured, acute, and chronic patients group. Colorectal cancer was found in 34 patients; nearly 
all of them had chronic schistosomiasis or amebiasis, whereas no CRC was detected in the 
other patients or control groups. It was concluded that large bowel cancer is strongly 
associated with chronic infectious gastrointestinal diseases. This study, though, was limited 
by the inability to adjust for potential confounders such as age and gender. Furthermore, the 
issue of correspondence between the population giving rise to the cases and that sampled 
for the controls was not addressed. To date, there have been no epidemiological studies 
conducted at the population level to verify the link between S. mansoni infestation and large 
bowel cancer. 
The pathological evidence supporting an association between S. mansoni infestation and 
colorectal carcinoma is rather weak. In 1956, Dimmette et al. (1956) failed to demonstrate 
any specific pathological changes in patients with simultaneous CRC and S. mansoni 
infestation, and considered the two conditions unrelated. Contrasting to these results, a 
recent study by Madbouly et al. (2007) has shown that S. mansoni-associated colorectal 
cancer has distinctive pathological features often similar to those of colitis-induced 
carcinoma (Fig. 2a,b). These include high percentage of multicentric tumours and mucinous 
adenocarcinoma, and the tendency of the tumour to present at an advanced stage with high 
risk of malignant lymph node invasion. Although direct causal inference is limited, this study 
indicates that S. mansoni infestation may exercise some influence on the prognosis of patients 
with CRC. Other studies have examined the pathological changes in endoscopic biopsies and 
cadaveric specimens from the colon of patients with S. mansoni colitis (Mohamed et al., 1990; 
Cheever et al., 1987). The gross pathological lesions were akin to those observed in patients 
with S. japonicum colitis. However, histological analysis of the specimens showed no evidence 
of atypism or carcinomatous changes. This discrepancy in pathologic findings may be 
explained by the larger number of eggs deposited by S. japonicum than S. mansoni worms, thus 
causing more pathological problems (Ishii et al., 1994). 
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Fig. 2a. Photomicrograph showing S. mansoni egg shell in a background of mucinous 
adenocarcinoma. H&E × 40 
 
Fig. 2b. Photomicrograph showing calcified and viable S. mansoni ova with granuloma 
formation in the muscularis propria of the sigmoid colon. H&E × 20 
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4.3 Mechanisms of tumorigenesis 
The exact etiopathogenesis of schistosomal colorectal cancer is enigmatic. Several 
explanations have been advanced for the possible role of schistosomiasis in colorectal 
tumorigenesis: the presence of endogenously produced carcinogens (Rosin et al., 1994), 
chronic immunomodulation resulting in impairment of immunological surveillance (van 
Riet et al., 2007), symbiotic action of other infective agents (Shindo, 1976), and the presence 
of schistosomal toxins (Long et al., 2004). While these factors may interact to induce 
carcinogenesis, chronic inflammation appears to play a central role. In support of this view 
are data showing that CRC tends to occur mainly in patients who had history of 
schistosomiasis for 10 years or more and in whom the large bowel is wholly involved 
(Shindo, 1976; Ming-Chai et al., 1980). Moreover, there is significantly higher rate of 
synchronous tumours in patients with schistosomal colorectal cancer than in patients with 
spontaneous colorectal cancer (Ming-Chai et al., 1980; Madbouly et al., 2007). This can be 
ascribed to the field effect caused by chronic schistosomal inflammation throughout the 
colon, a phenomenon analogous to that described in the context of colitis-associated cancer. 
It has been suggested that chronic inflammatory reaction provoked by schistosome antigens 
provides the proliferative stimulus necessary to promote cancer growth from potentially 
malignant foci produced by other carcinogens (Ming-Chai et al., 1980). However, whereas 
increased epithelial cell proliferation likely contributes to carcinogenesis, it is insufficient to 
cause cancer. Rather, inflammatory cells generate potentially genotoxic mediators during 
the course of schistosomal infection such as reactive oxygen and nitrogen species and 
proinflammatory cytokines, which cause genomic instability and dysregulation of 
oncogenes and oncosuppresor genes (Herrera et al., 2005; Trakatelli et al., 2005). The 
accumulation of these molecular disturbances, in turn, drives the progression toward 
dysplasia and carcinoma. Another factor that may play a major role in colorectal 
carcinogenesis of schistosomiasis patients is the presence of concomitant enterobacterial 
infections. In both clinical and experimental studies, various strains of enterobacteriaceae 
have been described in association with schistosome infection which confers a survival 
advantage to bacteria by inducing immunosuppression (Chieffi, 1992; Tuazon et al., 1985). 
Some of these organisms are thought to promote colorectal carcinogenesis through multiple 
pathways such as production of reactive oxygen intermediates, dysregulation in the T cell 
response, and alterations in host epithelial carbohydrate expression (Hope et al., 2005). 
A further explanation for the carcinogenic process of schistosomal CRC is a possible direct 
mutagenic effect of the schistosome soluble antigens. Evidence against this hypothesis has 
come from a study by Ishii et al. (1989), who evaluated the mutagenicity of S. japonicum 
extracts using the Ames Salmonella/E. coli test in the presence and absence of rat liver S9 
mixture. They did not identify any mutagenic activity for the soluble extracts of both eggs 
and adult worms. Nevertheless, a weak but significant tumour-promoting activity was 
noted for the S. japonicum soluble egg antigen when tested using cultured viral genome-
carrying human lymphoblastoid cells. Osada et al. (2005) tested the adult worm and egg 
extracts of S. mansoni using more reliable genetic toxicology assays, the Salmonella Umu test 
and the hypoxanthine guanine phosphoribosyltransferase (HGPRT) gene mutation assay. 
They could not demonstrate any mutagenic potential in either parasite extracts of S. mansoni 
before and after addition of S9 mixture. 
Recent studies have thrown some light on the molecular events associated with schistosomal 
colorectal cancer, taking the latter as a separate clinical entity. Zhang et al. (1998) investigated 
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the mutation pattern in the p53 gene in S. japonicum-associated rectal carcinomas. They 
observed a higher proportion of base-pair substitutions at CpG dinucleotides and arginine 
missense mutations among schistosomal rectal cancer patients than in patients with ordinary 
CRC, albeit the differences were of marginal significance. Their results also indicated that the 
majority of mutations in p53 gene were in exon 7 in schistosomal group compared to exon 5 in 
non-schistosomal group. Barrowing from the ulcerative colitis example, nitric oxide, an 
endogenously produced genotoxic agent, is capable of inducing similar transition mutations 
and activation of p53 gene in the inflamed colonic mucosa (Goodman et al., 2004). Conceivably 
therefore, it seems plausible that chronic colonic inflammation induced by schistosomal 
infection may follow a similar pathway. 
For S. mansoni-associated colorectal carcinomas, it was demonstrated that parasitism is 
strongly associated with microsatellite instability, which is a sign of defective DNA repair 
(Soliman et al., 2001). This genomic instability results in DNA replication errors that 
preferentially affect target genes such as transforming growth factor (TGH)βRII and insulin-
like growth factor (IGF)2R, and render them incapable of normal colonocytes homeostasis 
resulting in malignant growth (Itzkowitz & Yio, 2004). In another aspect, Madbouly et al. 
(2007) evaluated the expression of p53 in patients with S. mansoni-related colorectal cancer, 
and found that mutant p53 overexpression was significantly more frequent in schistosomal 
than in non-schistosomal colorectal cancer. Moreover, p53 overexpression in schistosomal 
CRC correlated well with mucinous carcinoma, nodal metastasis, and tumour 
multicentricity. Zalata et al. (2005) developed a more comprehensive study of the expression 
pattern of p53, Bcl-2, and c-myc in seventy five CRC cases, 24 of these had pathological 
evidence of S. mansoni infection. Although they did not find a significant association 
between parasitism and p53 and c-myc expression, their results showed that S. mansoni-
associated colorectal tumours characterized by Bcl-2 overexpression and less apoptotic 
activity than ordinary colorectal tumours. This supports the contention that evasion of 
apoptosis through change in the expression of Bcl-2 may be an alternative molecular 
pathway through which genotoxic agents can induce carcinogenesis in intestinal 
schistosomiasis. 
5. Concluding remarks 
It is clearly evident that a wide array of microbial agents is associated with colorectal cancer. 
Nonetheless, establishing a causal link between a certain organism and colorectal cancer is a 
complicated process, considering the long latency of infection during which numerous 
endogenous and exogenous factors interact to obscure causality. For most of these putative 
agents, the association has been inconsistent, and may either define subsets of the tumour, 
or may act to modify phenotype of an established tumour, possibly contributing to some 
phase of oncogenesis.  
Despite the fact that H. pylori and S. bovis were discovered in colorectal tumours and linked 
to the malignancy by seroepidemiologic studies and molecular analyses, these pathogens 
are considered to be at most contributing cofactors. The two reasons for this loss of 
etiological status were the inconsistency in the epidemiological data regarding H. pylori and 
S. bovis infections and risk of colorectal cancer (Gold et al, 2004; Y. S. Zhao et al., 2008), 
whereas none of these agents produced de novo colorectal cancer in animal models (Singh et 
al., 2000a; Biarc et al., 2004). The relation between gut mictobiota such as B. fragilis and E. 
www.intechopen.com
 The Role of Infectious Agents in Colorectal Carcinogenesis 
 
357 
faecalis and colorectal cancer is far less convincing. Although the oncogenic potential of B. 
fragilis and E. faecalis is not disputed, the scarcity of epidemiological evidence renders any 
association hypothetical.  
In case of viral agents, while HPV and JCV have oncogenic properties both in cell culture 
and experimental animals (Butel, 2000), the detection of viral genomes in tumour tissues is 
inconsistent, which can be attributed to the fact that PCR technique, used for detection of 
viral DNA in most studies, is subject to contamination. At this point, this precludes a 
causative role for these viruses in colorectal cancer, and obtaining more credible results 
mandates employment of combination of in situ methods for detection of viral genome and 
its products such as in situ cytohybridization and immunohistochemistry (Panago et al., 
2004). 
In case of S. japonicum, the growing epidemiological evidence and the unique clinic-
pathological features of schistosome-related colorectal cancer point to a reasonably 
consistent association. However, S. japonicum has been classified by IARC as possible and 
not as definite carcinogen in human leading to colorectal cancer (IARC, 1994). This perhaps 
reflects the confounding uncertainties presented by epidemiological studies and the lack of 
experimental evidence. For S. mansoni species, it is still a matter of controversy as to whether 
or not S. mansoni infection is an association factor in colorectal cancer development and 
progression. 
Infection-related colorectal carcinogenesis is a complex multistage process that utilizes 
several mechanisms. For most bacterial species and helminths associated with colorectal 
cancer, chronic inflammatory response and immunomodulation induced by secretory or 
structural proteins are the principal mechanisms of carcinogenesis. These involve release of 
protumorigenic mediators and dysregulation of multiple cellular transcriptional pathways 
including NF-κB and ǃ–catenin. Others such as H. pylori primarily induce production of 
growth factor resulting disruption of proliferation-antiproliferation pathways. DNA tumour 
viruses, such as HPV and JCV, primarily target cellular tumour suppressor proteins, thus 
modulating cell cycle progression (Butel, 2000).   
Together, our observations underpin the necessity of epidemiological studies focusing on 
specific strains such as CagA+ H. pylori, S. gallolyticus, ETBF, and Mad-1 JCV. In addition, 
the interaction between various infectious agents in relation to carcinogenesis, as illustrated 
in the additive effect of B. fragilis and E. faecalis needs further evaluation. Finally it is likely 
that more agents, both known and unidentified, have yet to be implicated in human 
colorectal cancer. In the meantime, study of tumorigenic infectious agents will continue to 
illuminate molecular oncogenic processes. 
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